Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of the Combination of Low-dose Ibrutinib and Itraconazole in Moderate to Severe Chronic Graft Versus Host Disease: a Phase 2 Trial
Conditions
Interventions
Low-dose ibrutinib
Locations
1
Mexico
Hospital Universitario Dr. José Eleuterio González
Monterrey, Nuevo León, Mexico
Start Date
April 1, 2022
Primary Completion Date
April 1, 2023
Completion Date
August 1, 2023
Last Updated
April 27, 2022
NCT07124078
NCT05305989
NCT03640481
NCT04200365
NCT05121142
NCT03689894
Lead Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions